I think the most overlooked factors right now are probably:
1) risk of pulmonary microthrombi (practice appears to be converging on prophylactic enoxaparin, see e.g. Yale guidance)
2) secretions, risk of hyaline membrane formation (consider ambroxol or similar, prone position)
1) risk of pulmonary microthrombi (practice appears to be converging on prophylactic enoxaparin, see e.g. Yale guidance)
2) secretions, risk of hyaline membrane formation (consider ambroxol or similar, prone position)
https://treeverse.app/ ">https://treeverse.app/">...